Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study

Purpose

    • Purpose: This study aims to understand what changes might predict the end of life in people with dementia with Lewy bodies (DLB). This information will help patients, caregivers, families, and health care professionals know what to expect in later stages of DLB. It will also help identify what changes might suggest that someone is approaching the end of life, and how to make that time a good experience.
    • Eligibility:  
      • Individuals with moderate DLB and their main caregiver willing to participate as a pair
      • Moderate DLB diagnosis as assessed by a Quick Dementia Rating System (QDRS score of >12)
      • Caregiver willing to complete a modified telephone interview for cognitive status (TICS-m score of >31)
      • Able and willing to answer questionnaires relating to the DLB and caregiver experience
    • Procedures: Each patient and care partner pair will attend study visits every 6 months through the end of life or 3 years. There is a virtual cohort and an in-person cohort with study visits occurring a the University of Florida in Gainesville, FL. Each study visit is expected to last 2-3 hours as each scale will be administered verbally.  

Contact information
Kaitlin Sovich
PACE-DLB@neurology.ufl.edu
352-733-3004

Study Information Flyer

Gender

N/A

Monetary compensation

Yes

Can be done from home

Yes

Keywords

dementia

Principal Investigator

Melissa Armstrong , Dr./Associate Professor

Department

Neurology

Contact Information

PACE-DLB@neurology.ufl.edu

352-733-2419


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at UFStudies@health.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams